82 FR 11236 - National Cancer Institute; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 33 (February 21, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 33 (February 21, 2017)
| Page Range | 11236-11236 | |
| FR Document | 2017-03282 |
[Federal Register Volume 82, Number 33 (Tuesday, February 21, 2017)] [Notices] [Page 11236] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-03282] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Provocative Question 2. Date: March 15, 2017. Time: 11:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W032, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Provocative Question 4. Date: March 16, 2017. Time: 12:30 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Bratin K. Saha, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W556, Bethesda, MD 20892-9750, 240-276-6411, [email protected]. Name of Committee: National Cancer Institute Special Emphasis Panel; Cell and Animal Models for Researching Disparities. Date: March 21, 2017. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W554, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Christopher L. Hatch, Ph.D., Chief, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W554, Rockville, MD 20892-9750, 240-276-6454, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 14, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-03282 Filed 2-17-17; 8:45 am] BILLING CODE 4140-01-P
![11236 Federal Register / Vol. 82, No. 33 / Tuesday, February 21, 2017 / Notices
The meetings will be closed to the DEPARTMENT OF HEALTH AND Contact Person: Christopher L. Hatch,
public in accordance with the HUMAN SERVICES Ph.D., Chief, Program Coordination and
provisions set forth in sections Referral Branch, Division of Extramural
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institutes of Health Activities, National Cancer Institute, NIH,
as amended. The grant applications and 9609 Medical Center Drive, Room 7W554,
National Cancer Institute; Notice of Rockville, MD 20892–9750, 240–276–6454,
the discussions could disclose Closed Meetings ch29v@nih.gov.
confidential trade secrets or commercial
property such as patentable material, Pursuant to section 10(d) of the (Catalogue of Federal Domestic Assistance
and personal information concerning Federal Advisory Committee Act, as Program Nos. 93.392, Cancer Construction;
amended (5 U.S.C. App.), notice is 93.393, Cancer Cause and Prevention
individuals associated with the grant
hereby given of the following meetings. Research; 93.394, Cancer Detection and
applications, the disclosure of which
The meetings will be closed to the Diagnosis Research; 93.395, Cancer
would constitute a clearly unwarranted Treatment Research; 93.396, Cancer Biology
invasion of personal privacy. public in accordance with the
provisions set forth in sections Research; 93.397, Cancer Centers Support;
Name of Committee: National Institute of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 93.398, Cancer Research Manpower; 93.399,
Child Health and Human Development as amended. The grant applications/ Cancer Control, National Institutes of Health,
Special Emphasis Panel; NICHD T35 contract proposals and the discussions HHS)
Teleconference Review. could disclose confidential trade secrets Dated: February 14, 2017.
Date: March 10, 2017. or commercial property such as Melanie J. Pantoja,
Time: 1:30 p.m. to 3:00 p.m. patentable material, and personal
Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory
information concerning individuals Committee Policy.
applications. associated with the grant applications/
Place: National Institutes of Health, 6710B [FR Doc. 2017–03282 Filed 2–17–17; 8:45 am]
contract proposals, the disclosure of
Rockledge Drive, Bethesda, MD 20817 which would constitute a clearly BILLING CODE 4140–01–P
(Telephone Conference Call). unwarranted invasion of personal
Contact Person: Sherry L. Dupere, Ph.D., privacy.
Chief, Scientific Review Branch, Scientific DEPARTMENT OF HEALTH AND
Review Branch, Eunice Kennedy Shriver Name of Committee: National Cancer HUMAN SERVICES
National Institute of Child Health and Institute Special Emphasis Panel; NCI
Provocative Question 2.
Human Development, NIH, National Date: March 15, 2017. National Institutes of Health
Institutes of Health, 6710B Rockledge Drive, Time: 11:00 a.m. to 5:30 p.m.
Bethesda, MD 20817, 301–451–3415, Agenda: To review and evaluate grant National Cancer Institute; Amended
duperes@mail.nih.gov. applications. Notice of Meeting
Name of Committee: National Institute of Place: National Cancer Institute Shady
Child Health and Human Development Grove, 9609 Medical Center Drive, Room Notice is hereby given of a change in
7W032, Rockville, MD 20850 (Telephone the meeting of the President’s Cancer
Special Emphasis Panel; Learning Disabilities
Conference Call). Panel, March 27, 2017, 9:00 a.m. to
Center. Contact Person: Jun Fang, Ph.D., Scientific
Date: April 20–21, 2017. Review Officer, Research Technology and March 28, 2017, 1:00 p.m., Kimpton
Time: 8:30 a.m. to 5:00 p.m. Contract Review Branch, Division of Hotel Palomar, Philadelphia, PA 19103
Agenda: To review and evaluate grant Extramural Activities, National Cancer which was published in the Federal
applications. Institute, NIH, 9609 Medical Center Drive, Register on February 1, 2017, 82 FR
Place: Beacon Hotel and Corporate Room 7W246, Bethesda, MD 20892–9750, 8944.
Quarters, 1615 Rhode Island Avenue NW., 240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer This meeting notice is amended to
Washington, DC 20036.
Contact Person: Marita R. Hopmann, Ph.D., Institute Special Emphasis Panel; NCI change the ending date and time from
Scientific Review Officer, Division of Provocative Question 4. March 28, 2017 at 1:00 p.m. to March
Date: March 16, 2017. 27, 2017 at 4:30 p.m. The agenda has
Scientific Review, National Institute of Child
Time: 12:30 p.m. to 5:30 p.m. also been amended as follows:
Health and Human Development, National Agenda: To review and evaluate grant
Institutes of Health, 6710B Rockledge Drive, applications.
‘‘Welcome and Introductions; Session 1:
Bethesda, MD 20817, (301) 435–6911, Place: National Cancer Institute Shady The Pricing and Payment Landscapes—
hopmannm@mail.nih.gov. Grove, 9609 Medical Center Drive, Room Framing the Issues—1 and 2; Session 2:
(Catalogue of Federal Domestic Assistance 7W556, Rockville, MD 20850 (Telephone Cancer Drug Value/Intervention
Program Nos. 93.864, Population Research; Conference Call). Framework; Public Comment; Session 3:
Contact Person: Bratin K. Saha, Ph.D., High-Cost/High Value Drugs; Session 4:
93.865, Research for Mothers and Children;
Scientific Review Officer, Program
93.929, Center for Medical Rehabilitation Coordination and Referral Branch, Division High-Cost/Modest Value Drugs; Public
Research; 93.209, Contraception and of Extramural Activities, National Cancer Comment; Wrap-Up and Next Steps.’’
Infertility Loan Repayment Program, National Institute, NIH, 9609 Medical Center Drive, The meeting is open to the public.
Institutes of Health, HHS) Room 7W556, Bethesda, MD 20892–9750,
Dated: February 14, 2017.
240–276–6411, sahab@mail.nih.gov.
Dated: February 14, 2017. Melanie J. Pantoja,
Name of Committee: National Cancer
Michelle Trout, Institute Special Emphasis Panel; Cell and Program Analyst, Office of Federal Advisory
Program Analyst, Office of Federal Advisory
sradovich on DSK3GMQ082PROD with NOTICES
Animal Models for Researching Disparities. Committee Policy.
Committee Policy. Date: March 21, 2017. [FR Doc. 2017–03274 Filed 2–17–17; 8:45 am]
[FR Doc. 2017–03277 Filed 2–17–17; 8:45 am] Time: 12:00 p.m. to 5:00 p.m.
BILLING CODE 4140–01–P
Agenda: To review and evaluate contract
BILLING CODE 4140–01–P
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W554, Rockville, MD 20850 (Telephone
Conference Call).
VerDate Sep<11>2014 17:15 Feb 17, 2017 Jkt 241001 PO 00000 Frm 00066 Fmt 4703 Sfmt 9990 E:\FR\FM\21FEN1.SGM 21FEN1](https://thefederalregister.org/doc/82_FR_11269/page/1.svg)
Document Created: 2018-02-01 15:04:34
Document Modified: 2018-02-01 15:04:34
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | March 15, 2017. | |
| FR Citation | 82 FR 11236 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR